RESistance Under Combinatorial Treatment in ER+ and ER- Breast Cancer
Produced by: Morten Skoglund, Section of Medical Informatics, UIO Illustrations: Håkon Jøssang, Voice: Tim Hughes
The RESCUER consortium consists of fifteen organizations from ten different countries (Belgium, Finland, France, Germany, Israel, Norway, Spain, Sweden, United Kingdom, United States) and gathers all the relevant expertise and facilities to solve the challenge of identifying novel characterization methods for breast cancer drug resistance and new knowledge on effective combinatorial treatments.
News
-
How to pave the way for more outstanding research after an EU coordinator project? Jan. 19, 2024 10:12 AM
-
Article in Open Access Government Oct. 27, 2023 2:21 PM
-
PhD in the framework of the CEA Biomarker Focus project May 19, 2022 8:15 AM
Funded Doctoral (PhD) position: Characterization and functional validation of epigenetic changes implicated in the response to cancer immunotherapy
